198 related articles for article (PubMed ID: 19327102)
1. Prevention of diabetic ketoacidosis and self-monitoring of ketone bodies: an overview.
Weber C; Kocher S; Neeser K; Joshi SR
Curr Med Res Opin; 2009 May; 25(5):1197-207. PubMed ID: 19327102
[TBL] [Abstract][Full Text] [Related]
2. Microneedle-Based Detection of Ketone Bodies along with Glucose and Lactate: Toward Real-Time Continuous Interstitial Fluid Monitoring of Diabetic Ketosis and Ketoacidosis.
Teymourian H; Moonla C; Tehrani F; Vargas E; Aghavali R; Barfidokht A; Tangkuaram T; Mercier PP; Dassau E; Wang J
Anal Chem; 2020 Jan; 92(2):2291-2300. PubMed ID: 31874029
[TBL] [Abstract][Full Text] [Related]
3. Can we prevent diabetic ketoacidosis in children?
Bismuth E; Laffel L
Pediatr Diabetes; 2007 Oct; 8 Suppl 6():24-33. PubMed ID: 17727382
[TBL] [Abstract][Full Text] [Related]
4. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial.
Laffel LM; Wentzell K; Loughlin C; Tovar A; Moltz K; Brink S
Diabet Med; 2006 Mar; 23(3):278-84. PubMed ID: 16492211
[TBL] [Abstract][Full Text] [Related]
5. Screening for ketonemia in patients with diabetes.
Schwab TM; Hendey GW; Soliz TC
Ann Emerg Med; 1999 Sep; 34(3):342-6. PubMed ID: 10459090
[TBL] [Abstract][Full Text] [Related]
6. Sick-day management in type 1 diabetes.
Laffel L
Endocrinol Metab Clin North Am; 2000 Dec; 29(4):707-23. PubMed ID: 11149158
[TBL] [Abstract][Full Text] [Related]
7. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors.
Fleming N; Hamblin PS; Story D; Ekinci EI
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32302001
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, Cost, and Burden of Diabetic Ketoacidosis.
Virdi N; Poon Y; Abaniel R; Bergenstal RM
Diabetes Technol Ther; 2023 Jun; 25(S3):S75-S84. PubMed ID: 37306442
[TBL] [Abstract][Full Text] [Related]
9. Diabetic ketoacidosis: risk factors and management strategies.
Umpierrez GE; Kitabchi AE
Treat Endocrinol; 2003; 2(2):95-108. PubMed ID: 15871546
[TBL] [Abstract][Full Text] [Related]
10. Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis.
Umpierrez GE; DiGirolamo M; Tuvlin JA; Isaacs SD; Bhoola SM; Kokko JP
J Crit Care; 2000 Jun; 15(2):52-9. PubMed ID: 10877365
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the monitoring and management of diabetic ketoacidosis.
Wallace TM; Matthews DR
QJM; 2004 Dec; 97(12):773-80. PubMed ID: 15569808
[TBL] [Abstract][Full Text] [Related]
12. Development of Machine Learning Models for the Identification of Elevated Ketone Bodies During Hyperglycemia in Patients with Type 1 Diabetes.
Lebech Cichosz S; Bender C
Diabetes Technol Ther; 2024 Jun; 26(6):403-410. PubMed ID: 38456910
[No Abstract] [Full Text] [Related]
13. Diabetic ketoacidosis in a community of suburban Osaka. Analysis of 39 episodes of ketoacidosis and related conditions.
Yamamoto T
Endocrinol Jpn; 1983 Feb; 30(1):43-54. PubMed ID: 6411456
[TBL] [Abstract][Full Text] [Related]
14. Recurrent diabetic ketoacidosis and a brief history of brittle diabetes research: contemporary and past evidence in diabetic ketoacidosis research including mortality, mental health and prevention.
Garrett CJ; Choudhary P; Amiel SA; Fonagy P; Ismail K
Diabet Med; 2019 Nov; 36(11):1329-1335. PubMed ID: 31418474
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices.
Vanelli M; Chiari G; Ghizzoni L; Costi G; Giacalone T; Chiarelli F
Diabetes Care; 1999 Jan; 22(1):7-9. PubMed ID: 10333896
[TBL] [Abstract][Full Text] [Related]
16. SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Goldenberg RM; Berard LD; Cheng AYY; Gilbert JD; Verma S; Woo VC; Yale JF
Clin Ther; 2016 Dec; 38(12):2654-2664.e1. PubMed ID: 28003053
[TBL] [Abstract][Full Text] [Related]
17. Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes.
Peters AL; Henry RR; Thakkar P; Tong C; Alba M
Diabetes Care; 2016 Apr; 39(4):532-8. PubMed ID: 26989182
[TBL] [Abstract][Full Text] [Related]
18. Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
Polcwiartek C; Vang T; Bruhn CH; Hashemi N; Rosenzweig M; Nielsen J
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3663-3672. PubMed ID: 27592232
[TBL] [Abstract][Full Text] [Related]
19. [Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State].
Schumann C; Faust M
Dtsch Med Wochenschr; 2018 Mar; 143(6):384-391. PubMed ID: 29544233
[TBL] [Abstract][Full Text] [Related]
20. Postmortem
Heimer J; Gascho D; Chatzaraki V; Knaute DF; Sterzik V; Martinez RM; Thali MJ; Zoelch N
Int J Legal Med; 2018 Mar; 132(2):593-598. PubMed ID: 29170817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
